Indication

Psilocybin Treatment in Individuals With Functional Impairment Due to Psychiatric Symptoms

1 clinical trial

1 product

Clinical trial

Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study

Status: Not yet recruiting, Estimated PCD: 2027-07-01

Product